Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bolli

Showing results (921-930 of 1,218) with videos related to

Pageof 122
Sort By:
Diabetes Technology & Therapeutics|February 4, 2016
Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 DiabetesMatthew C Riddle, Geremia B Bolli, Philip D Home, et al.
Diabetes Technology & Therapeutics|August 16, 2016
Insulin Infusion Set Use: European Perspectives and RecommendationsDorothee Deiss, Peter Adolfsson, Marije Alkemade-van Zomeren, et al.
Archives of Internal Medicine|May 30, 2007
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysisAhmed Abdel-Latif, Roberto Bolli, Imad M Tleyjeh, et al.
The American Journal of Physiology|May 18, 1999
PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbitsP Ping, J Zhang, X Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancerA F Sobrero, C Aschele, A P Guglielmi, et al.
Diabetes Technology & Therapeutics|August 26, 2011
International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, GreeceGeremia B Bolli, Larry C Deeb, Satish K Garg, et al.
European Journal of Medicinal Chemistry|March 31, 2016
Novel S1P1 receptor agonists - Part 5: From amino-to alkoxy-pyridinesMartin H Bolli, Cyrille Lescop, Magdalena Birker, et al.
Dalton Transactions (Cambridge, England : 2003)|November 24, 2022
Tunable physics through coordination chemistry: formation on oxide surface of Ti and Al chelates with 3-hydroxyflavone capable of electron injection and light emissionGetachew Solomon, Anton Landström, Silvia Rotta Loria, et al.
Chemmedchem|July 9, 2016
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping ApproachBibia Heidmann, John Gatfield, Catherine Roch, et al.
Chirurgia Italiana|September 27, 2006
[Diagnostic-therapeutic pathways as instruments of clinical management: experience at the S. Maria Hospital in Terni]Roberta Lucchini, Daniela Donetti, Michele D'Ajello, et al.
Pageof 122

Showing results (921-930 of 1,218) with videos related to

Sort By:
Pageof 122
Diabetes Technology & Therapeutics|February 4, 2016
Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 DiabetesMatthew C Riddle, Geremia B Bolli, Philip D Home, et al.
Diabetes Technology & Therapeutics|August 16, 2016
Insulin Infusion Set Use: European Perspectives and RecommendationsDorothee Deiss, Peter Adolfsson, Marije Alkemade-van Zomeren, et al.
Archives of Internal Medicine|May 30, 2007
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysisAhmed Abdel-Latif, Roberto Bolli, Imad M Tleyjeh, et al.
The American Journal of Physiology|May 18, 1999
PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbitsP Ping, J Zhang, X Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancerA F Sobrero, C Aschele, A P Guglielmi, et al.
Diabetes Technology & Therapeutics|August 26, 2011
International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, GreeceGeremia B Bolli, Larry C Deeb, Satish K Garg, et al.
European Journal of Medicinal Chemistry|March 31, 2016
Novel S1P1 receptor agonists - Part 5: From amino-to alkoxy-pyridinesMartin H Bolli, Cyrille Lescop, Magdalena Birker, et al.
Dalton Transactions (Cambridge, England : 2003)|November 24, 2022
Tunable physics through coordination chemistry: formation on oxide surface of Ti and Al chelates with 3-hydroxyflavone capable of electron injection and light emissionGetachew Solomon, Anton Landström, Silvia Rotta Loria, et al.
Chemmedchem|July 9, 2016
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping ApproachBibia Heidmann, John Gatfield, Catherine Roch, et al.
Chirurgia Italiana|September 27, 2006
[Diagnostic-therapeutic pathways as instruments of clinical management: experience at the S. Maria Hospital in Terni]Roberta Lucchini, Daniela Donetti, Michele D'Ajello, et al.
Pageof 122